Extended reports
Technetium-99m labelled liposomes to image experimental arthritis
a Departments of Nuclear Medicine , b and
Internal Medicine , c University Hospital Nijmegen, the Netherlands
Department of Pharmaceutics, Utrecht
Institute for Pharmaceutical Sciences, University Utrecht, the
Netherlands , d Departamento de Biotecnologia, IBQTA-INETI,
Portugal
Correspondence to: Dr O C Boerman, Department of Nuclear Medicine, University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, the Netherlands.
Accepted for publication 24 February 1997
OBJECTIVES
Liposomes sterically stabilised with
polyethylene glycol (PEG) labelled with technetium-99m were tested for
their ability to image adjuvant arthritis in a rat model.
METHODS
Adjuvant arthritis was induced in the
ankle joint of the left hind foot by injection of Mycobacterium
butyricum in Freund's incomplete adjuvant in the foot pad.
Seven days later animals received the following radiopharmaceuticals
labelled with 99mTc (a) non-PEG-liposomes, (b)
PEG-liposomes or (c) non-specific human polyclonal IgG. For each of the
radiopharmaceuticals the in vivo distribution of the radiolabel was
monitored both scintigraphically as well as by counting the dissected
tissues at two, eight, and 24 hours after injection.
RESULTS
The pharmacokinetics of the
radiopharmaceuticals differed considerably (half life in the blood:
PEG-liposomes (18 hours) > 99mTc-IgG (3 hours) > non-PEG
liposomes (1 hour)). The inflamed focus was visualised with each of the
agents. The uptake of each of the radiopharmaceuticals in the
inflamed ankle region correlated with their residence time in the blood
(inflamed joint uptake: PEG liposomes (1.15% injected dose
(ID)/g)>99mTc-IgG (0.35% ID/g)>non-PEG-liposomes (0.05%
ID/g)). Quantitative analysis of the images showed that the inflamed
ankle to background ratio was highest with the PEG-liposomes (7.5 at 24 hours after injection), while with the other two agents this ratio did
not exceed 4.
CONCLUSION
This study shows that
99mTc-labelled PEG-liposomes may be an excellent agent to
visualise arthritis. Increased label uptake in the inflamed joint and
increased target to background ratios can be obtained with
PEG-liposomes because of their long circulating properties. In addition
to their use as vehicles for scintigraphic imaging of arthritis
PEG-liposomes might also be used for the site specific delivery of
antirheumatic drugs.
© 1997 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Tuffin, G., Waelti, E., Huwyler, J., Hammer, C., Marti, H.-P.
(2005). Immunoliposome Targeting to Mesangial Cells: A Promising Strategy for Specific Drug Delivery to the Kidney. J. Am. Soc. Nephrol.
16: 3295-3305
[Abstract] [Full Text] -
Moghimi, S. M., Hunter, A. C., Murray, J. C.
(2001). Long-Circulating and Target-Specific Nanoparticles: Theory to Practice. Pharmacol. Rev.
53: 283-318
[Abstract] [Full Text] -
Laverman, P., Brouwers, A. H., Th. M. Dams, E., Oyen, W. J. G., Storm, G., van Rooijen, N., Corstens, F. H. M., Boerman, O. C.
(2000). Preclinical and Clinical Evidence for Disappearance of Long-Circulating Characteristics of Polyethylene Glycol Liposomes at Low Lipid Dose. J. Pharmacol. Exp. Ther.
293: 996-1001
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
